Literature DB >> 27230700

Dialysis and Patient Factors Which Determine Convective Volume Exchange in Patients Treated by Postdilution Online Hemodiafiltration.

Andrew Davenport1.   

Abstract

Recent reports suggest a survival advantage for dialysis patients treated by postdilutional online hemodiafiltration (OL-HDF) who achieve higher volume convective exchanges. As such, the factors associated with achieving higher convective volume exchange were determined. The convective exchange volumes during the midweek OL-HDF session in a cohort of 653 patients with corresponding bio-impedance measurements of volume status and sessional electronic records were audited. Mean patient age was 64.9 ± 14.9 years, 65.3% male, 47.7% diabetes, with 81.6% dialyzing using fistula access. Sessional substitution volume exchanged was 17.0 ± 3.5 L (83.8 ± 13.9 mL/min), with a filtration fraction of 23.3 ± 4.6%, sessional time of 3.8 ± 0.5 h, and blood flow 321 ± 28 mL/min. As expected, convection exchange volume achieved was associated with sessional time (β 3.24, P < 0.001), blood flow (β 0.03, P < 0.001), dialysate flow (β 0.03, P < 0.001), but also patient factors: postsessional intracellular water (ICW) (β 0.07, P = 0.002), and serum albumin (β 0.71, P = 0.011). In addition convective exchange was lower for diabetics (16.6 ± 3.0 vs. 17.3 ± 3.8 L, P < 0.01), and for patients with higher Davies co-morbidity grades (16.6 ± 2.8 vs. 17.0 ± 3.6 vs. 17.9 ± 4.0 L), P = 0.01 respectively. As expected the convective volume exchanged with OL-HDF was associated with sessional time and blood and dialysate flows. However, the convective volume exchange achieved was also associated with patient factors, including ICW, which is related to body cell mass and also co-morbidity. Although some center practices can be modified to increase convective exchange, patient factors are not so readily remediable. As such, highly comorbid patients may not be able to achieve the higher volume convective exchanges reported to be associated with improved patient survival.
Copyright © 2016 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  Comorbidity; Filtration fraction; Hemodiafiltration; Online; Postdilution; Total body water

Mesh:

Substances:

Year:  2016        PMID: 27230700     DOI: 10.1111/aor.12709

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

1.  Efficacy of Supra-HFR in Removing FGF23 and Cytokines: A Single Session Analysis.

Authors:  Gabriele Donati; Andrea Angeletti; Maria Cappuccilli; Chiara Donadei; Chiara Guglielmo; Anna Scrivo; Lorenzo Gasperoni; Maddalena Zambelli; Maria Mattiotti; Gaetano La Manna
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.

Authors:  Peter J Blankestijn; Kathrin I Fischer; Claudia Barth; Krister Cromm; Bernard Canaud; Andrew Davenport; Diederick E Grobbee; Jörgen Hegbrant; Kit C Roes; Matthias Rose; Giovanni Fm Strippoli; Robin Wm Vernooij; Mark Woodward; G Ardine de Wit; Michiel L Bots
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.